LAS VEGAS, Oct. 8, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV - News), a developer of innovative drugs, announced today its CEO Dr. Janet Greeson will highlight drugs in Samaritan's clinical pipeline that offer a substantial benefit over what is already on the market, with the objective of finding a Pharma partner or a licensing deal, at Bio Partnering Europe in London, England, October 8-9, 2007.
